Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H G Watson

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Bone Marrow Transplantation|June 11, 2003
Use of recombinant factor VIIa in life-threatening bleeding following autologous peripheral blood stem cell transplantation complicated by platelet refractorinessD J Culligan, A Salamat, J Tait, et al.
Journal of Thrombosis and Haemostasis : JTH|February 12, 2016
An observational study of direct oral anticoagulant awareness indicating inadequate recognition with potential for patient harmA Olaiya, B Lurie, B Watt, et al.
The Journal of Laryngology and Otology|March 29, 2001
Combined risk factors contributing to cerebral venous thrombosis in a young womanB Ram, D J Meiklejohn, D A Nunez, et al.
British Journal of Haematology|November 28, 2001
A comparison of the efficacy and rate of response to oral and intravenous Vitamin K in reversal of over-anticoagulation with warfarinH G Watson, T Baglin, S L Laidlaw, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Hepatitis B serology and DNA detection in multitransfused haemophiliacs and factor VIII and IX concentratesH G Watson, C A Ludlam, S Rebus, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|May 1, 1996
Evolution of zidovudine resistance-associated genotypes in human immunodeficiency virus type 1-infected patientsA Cleland, H G Watson, P Robertson, et al.
British Journal of Haematology|January 1, 1995
Absence of hepatitis A virus transmission by high-purity solvent detergent treated coagulation factor concentrates in Scottish haemophiliacsH G Watson, C A Ludlam, F McOmish, et al.
British Journal of Haematology|November 23, 2006
Safety indicators for inpatient and outpatient oral anticoagulant care: [corrected] Recommendations from the British Committee for Standards in Haematology and National Patient Safety AgencyT P Baglin, D Cousins, D M Keeling, et al.
Vox Sanguinis|October 9, 2002
Transfusion-associated graft-versus-host disease in a patient with Waldenstrom's macroglobulinaemiaL R Munro, D J Culligan, A Grant, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 23, 2013
Update to UKHCDO guidance on vaccination against hepatitis A and B viruses in patients with inherited coagulation factor deficiencies and von Willebrand diseaseH G Watson, J T Wilde, G Dolan, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Bone Marrow Transplantation|June 11, 2003
Use of recombinant factor VIIa in life-threatening bleeding following autologous peripheral blood stem cell transplantation complicated by platelet refractorinessD J Culligan, A Salamat, J Tait, et al.
Journal of Thrombosis and Haemostasis : JTH|February 12, 2016
An observational study of direct oral anticoagulant awareness indicating inadequate recognition with potential for patient harmA Olaiya, B Lurie, B Watt, et al.
The Journal of Laryngology and Otology|March 29, 2001
Combined risk factors contributing to cerebral venous thrombosis in a young womanB Ram, D J Meiklejohn, D A Nunez, et al.
British Journal of Haematology|November 28, 2001
A comparison of the efficacy and rate of response to oral and intravenous Vitamin K in reversal of over-anticoagulation with warfarinH G Watson, T Baglin, S L Laidlaw, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Hepatitis B serology and DNA detection in multitransfused haemophiliacs and factor VIII and IX concentratesH G Watson, C A Ludlam, S Rebus, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|May 1, 1996
Evolution of zidovudine resistance-associated genotypes in human immunodeficiency virus type 1-infected patientsA Cleland, H G Watson, P Robertson, et al.
British Journal of Haematology|January 1, 1995
Absence of hepatitis A virus transmission by high-purity solvent detergent treated coagulation factor concentrates in Scottish haemophiliacsH G Watson, C A Ludlam, F McOmish, et al.
British Journal of Haematology|November 23, 2006
Safety indicators for inpatient and outpatient oral anticoagulant care: [corrected] Recommendations from the British Committee for Standards in Haematology and National Patient Safety AgencyT P Baglin, D Cousins, D M Keeling, et al.
Vox Sanguinis|October 9, 2002
Transfusion-associated graft-versus-host disease in a patient with Waldenstrom's macroglobulinaemiaL R Munro, D J Culligan, A Grant, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 23, 2013
Update to UKHCDO guidance on vaccination against hepatitis A and B viruses in patients with inherited coagulation factor deficiencies and von Willebrand diseaseH G Watson, J T Wilde, G Dolan, et al.
Pageof 6